TCL Archive Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget October 1, 1982
TCL Archive Beyond Planned Parenthood: Attendance Flags at Komen Flagship Race, D.C. Participation Drops by Nearly One-Third June 8, 2012
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction April 28, 2006
